Get comprehensive Multiple Myeloma Monitoring Panel Test for only $262 USD. Essential blood cancer monitoring with CBC
Get comprehensive Metanephrines Fractionated Random Urine Test for only $212 in USA. Early detection of pheochromocytoma tumors through advanced HPLC-EC analysis. Available in New York Metanephrines Fractionated Random Urine Test Original price was: $376.Current price is: $212.
Get your Neuron Specific Enolase NSE Serum Test for only $112 USD (regularly $200) across USA. Same-day results available for neuroendocrine tumor detection and monitoring. Book now at GGC DNA for comprehensive cancer screening in New York Neuron Specific Enolase NSE Serum Test Original price was: $200.Current price is: $112.
Sale!

Multiple Myeloma Monitoring Panel Test

Original price was: $312.Current price is: $262.

-16%

The Multiple Myeloma Monitoring Panel Test is a comprehensive diagnostic tool designed to track and monitor multiple myeloma, a serious blood cancer affecting plasma cells. This panel combines multiple essential tests including complete blood count, protein electrophoresis, immunotyping, and light chain analysis to provide a complete picture of disease progression and treatment response. The test helps detect abnormal plasma cell activity, monitor treatment effectiveness, and identify potential complications. At just $262 USD, this panel offers exceptional value for comprehensive cancer monitoring. No special preparation is required, and results are typically available the next working day. Our advanced testing methods include capillary electrophoresis, immunoturbidimetry, and nephelometry for accurate results. This test is particularly important for patients undergoing multiple myeloma treatment or those in remission to ensure early detection of recurrence.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Multiple Myeloma Monitoring Panel Test

Comprehensive Blood Cancer Monitoring and Management

The Multiple Myeloma Monitoring Panel Test represents a sophisticated diagnostic approach specifically designed for patients battling multiple myeloma, a complex blood cancer that affects plasma cells in the bone marrow. This comprehensive panel provides healthcare providers with essential data to monitor disease progression, evaluate treatment effectiveness, and detect early signs of recurrence or complications.

What This Advanced Panel Measures

Our Multiple Myeloma Monitoring Panel incorporates multiple critical laboratory assessments to deliver a complete clinical picture:

  • Complete Blood Count (CBC): Evaluates red blood cells, white blood cells, and platelets to detect anemia and other blood abnormalities
  • Renal Function Tests: Urea and creatinine measurements to assess kidney function, commonly affected in multiple myeloma
  • Calcium and Albumin: Monitors calcium levels that can become elevated due to bone destruction
  • LDH (Lactate Dehydrogenase): An enzyme marker that can indicate disease activity and tumor burden
  • Beta 2 Microglobulin: A key prognostic marker for multiple myeloma staging and monitoring
  • Protein Electrophoresis: Identifies and quantifies abnormal monoclonal proteins (M-proteins)
  • Immunotyping: Characterizes the specific type of immunoglobulin being produced abnormally
  • Kappa/Lambda Light Chains: Measures free light chains to detect light chain myeloma
  • Immunoglobulin Profile: Assesses overall antibody levels and immune system function

Who Should Consider This Essential Monitoring Test

This comprehensive panel is specifically recommended for:

  • Patients currently diagnosed with multiple myeloma undergoing treatment
  • Individuals in remission from multiple myeloma requiring regular surveillance
  • Patients experiencing symptoms suggesting disease progression or recurrence
  • Those with monoclonal gammopathy of undetermined significance (MGUS) being monitored for progression
  • Individuals with unexplained bone pain, fatigue, recurrent infections, or kidney dysfunction
  • Patients showing signs of anemia, hypercalcemia, or renal impairment

Significant Benefits of Regular Monitoring

Regular monitoring with our comprehensive panel provides numerous clinical advantages:

  • Early Detection of Progression: Identifies disease recurrence or progression before symptoms appear
  • Treatment Optimization: Helps oncologists adjust therapy based on objective response markers
  • Complication Prevention: Monitors for kidney damage, bone complications, and other myeloma-related issues
  • Prognostic Information: Provides data for risk stratification and long-term prognosis assessment
  • Peace of Mind: Regular monitoring reduces anxiety by providing concrete data about disease status
  • Personalized Care: Enables tailored treatment approaches based on individual response patterns

Understanding Your Test Results

Your Multiple Myeloma Monitoring Panel results will be interpreted by our expert hematology-oncology team. Key aspects to understand include:

  • M-protein Levels: Decreasing levels typically indicate positive treatment response
  • Light Chain Ratios: Normalization suggests improved disease control
  • Beta 2 Microglobulin: Lower levels correlate with better prognosis and treatment response
  • Blood Counts: Improvement in anemia and other cytopenias indicates bone marrow recovery
  • Renal Function: Stable or improved kidney function suggests good disease control
  • Calcium Levels: Normalization indicates reduced bone destruction activity

It’s essential to discuss your specific results with your oncologist, who will consider your complete clinical picture, treatment history, and individual health status.

Test Pricing and Availability

Test Name Discount Price Regular Price
Multiple Myeloma Monitoring Panel Test $262 USD $312 USD

Convenient Testing Process

Our testing process is designed for maximum convenience and accuracy:

  • Sample Collection: 3 mL whole blood in EDTA tube AND 5 mL serum from SST tube
  • Turnaround Time: Sample daily by 9 AM, results next working day
  • Preparation: No special preparation required
  • Shipping: Samples shipped refrigerated (DO NOT FREEZE)

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network ensures you receive the same high-quality testing and rapid results regardless of location.

Take Control of Your Health Journey

Don’t leave your multiple myeloma monitoring to chance. Our comprehensive panel provides the essential data your healthcare team needs to make informed decisions about your treatment and care. With rapid next-day results and no special preparation required, staying on top of your health has never been easier.

Ready to schedule your Multiple Myeloma Monitoring Panel Test? Contact us today at +1(267) 388-9828 or book your appointment online. Our dedicated team is ready to assist you with convenient scheduling and answer any questions about the testing process.

Take the next step in managing your multiple myeloma with confidence and comprehensive monitoring from America’s trusted diagnostic provider.

SKU: 1695 Category:

Related products